Searchable abstracts of presentations at key conferences in endocrinology

ea0022p660 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Trends in acromegaly treatment in Spain

Sesmilo Gemma , Gaztambide Sonia , Pico Antonio , Soto Alfonso , Torres Elena , Fajardo Carmen , Blanco Concepcion , Webb Susan

The Spanish acromegaly registry (REA) is an online epidemiological database created in 1997 to collect clinical and biochemical data of patients with acromegaly followed in Spain.Aim: To study trends in acromegaly treatment over time in Spain.Methods: REA is an online database in which registered endocrinologists collect data from all acromegalic patients seen at their practices in Spain. In the last year the neuroendocrine group o...

ea0021oc1.7 | Diabetes and metabolism | SFEBES2009

Prospective changes in glucocorticoid metabolism predict alterations in metabolic phenotype

Gray Joanna , McCarthy Theresa , Hughes Susan , Hughes Beverly , Stewart Paul , Tomlinson Jeremy

Glucocorticoid (GC) production rates are elevated in obese, insulin resistant individuals. We and others have demonstrated decreased hepatic cortisol regeneration through reduced 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity that converts inactive cortisone to cortisol. In addition, there is enhanced cortisol clearance by A-ring reductases, (notably 5α-reductase). We have argued that these changes drive the hypothalamo-pituitary–adrenal axis a...

ea0020htc5 | Hot topics: Clinical | ECE2009

ESE Young Investigator Award

Neggers Sebastian , Herder Wouter , Feelders Richard , Badia Xavier , Webb Susan , Lely Aart-Jan

Objective: To assess if weekly administration of 40 mg pegvisomant (PEG-V) improves quality of life (QoL) and metabolic parameters in acromegalic patients with already normal age-adjusted insulin-like growth factor-I (IGF-I) concentrations during long-acting somatostatin analog (SSA) treatment.Design: Prospective investigator-initiated, double blind, placebo controlled, cross-over study. Twenty acromegalic subjects received for two consecutive treatment ...

ea0020p463 | Obesity and Metabolism | ECE2009

Are hypothalamic oscillators dysfunctional with high fat feeding?

Namvar Sara , Gyte Amie , Birtles Susan , Myatt John , Leighton Brendan , Piggins Hugh

Circadian rhythms in behaviours and gene expression are driven by the autonomously rhythmic cells of the hypothalamic suprachiasmatic nucleus (SCN). In nocturnal rodents, restricting a daily meal to the lights-on phase, leads to entrainment of behaviour and gene expression in many extra-SCN hypothalamic nuclei and peripheral tissues. This anticipatory activity is independent of the SCN and is likely to arise from the activities of multiple hypothalamic centres including the do...

ea0016s2.3 | TGFβ superfamily | ECE2008

TGF-β family ligands in glucose and fat homeostasis in adults

Schneyer Alan , Bonner-Weir Susan , Mukherjee Abir , Sidis Yisrael , Thomas Melissa

The bioavailability of activin, GDF11, and myostatin, members of the TGFβ superfamily, is regulated by the soluble antagonists follistatin (FST) and follistatin like-3 (FSTL3). Activin influences tissue fate determination and organogenesis in embryos as well as organ homeostasis in adults while myostatin decreases muscle mass in adults and GDF11 regulates pancreatic β-cell differentiation. In addition, the FST gene produces three protein forms (FST288, FST303, and FS...

ea0016p509 | Obesity | ECE2008

Interleukin-1sz is a positive regulator of TIARP/STAMP2 in 3T3-L1 adipocytes

Sommer Grit , Kralisch Susan , Weise Sebastian , Ulrike Lossner , Matthias Bluher , Michael Stumvoll , Mathias Fasshauer

Tumor necrosis factor alpha-induced adipose-related protein (TIARP)/six-transmembrane protein of prostate 2 (STAMP2) has been characterized as an adipocyte-expressed protein which might play a crucial role in metabolic homeostasis and inflammatory pathways. In the current study, the impact of insulin resistance-inducing and proinflammatory interleukin (IL)-1ß on TIARP/STAMP2 gene expression was determined by quantitative real-time reverse transcription-polymerase chain re...

ea0015oc20 | Tumours, diabetes, bone | SFEBES2008

Serum 18 hydroxycortisol identifies aldosteronoma in the differential diagnosis of primary aldosteronism

Narasimhan Sowmya , McGregor Alan , Miell John , Chambers Susan Mary , Abraha (Daines) Hagosa Demoz , Aylwin Simon

Introduction: 18-hydroxycortisol (18-OHF) is known to be elevated in glucocorticoid remediable aldosteronism but there are few data relating to 18-OHF in the differential diagnosis of primary aldosteronism.Aim: We evaluated the usefulness of lying and standing 18-OHF in patients with primary aldosteronism in differentiating between aldosteronoma, bilateral adrenal hyperplasia (BAH) and normality.Methods: Patients (n=27) with...

ea0015p158 | Diabetes, metabolism and cardiovascular | SFEBES2008

Glucocorticoid metabolism in human obesity; increased 5α-reductase activity is associated with insulin resistance in both men and women

Tomlinson Jeremy , Hughes Beverly , Hughes Susan , Vassiliadi Dimitra , Arlt Wiebke , Stewart Paul

The role of endogenous glucocorticoid (GC) production and metabolism in the pathogenesis of obesity, insulin resistance and type 2 diabetes remains unclear. Patients with Cushing’s syndrome develop central obesity, insulin resistance and in some cases type 2 diabetes (T2DM), yet circulating cortisol levels are not elevated in simple obesity. Alterations in GC metabolism, including 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) that generates active cortisol ...

ea0014p348 | (1) | ECE2007

Removal of tick box for TFT in pathology request forms reduces TFT performed during acute medical admission

Piya Milan , Belbase Biparna , Thapa Meenakshi , Koppada Anu , Myers Martin , Baxter Susan , Rajbhandari Satyan

Joint UK guideline (2006) recommends that routine testing of thyroid function (TFT) in patients admitted acutely to hospital is not warranted unless specific clinical indications exist. Despite this, TFT is frequently requested during acute medical admission. In our previous audit in 2002, during a 1 month period from 18th September, 458 subjects were admitted to medical assessment unit (MAU) and 183 (40%) were offered TFT. 39 (29%) results were beyond the laboratory reference...

ea0013p296 | Thyroid | SFEBES2007

Removal of tick box for TFT in pathology request forms reduces TFT performed during acute medical admission

Piya Milan , Belbase Biparna , Karki-Thapa Meenakshi , Baxter Susan , Myers M , Koppada A , Rajbhandari Satyan Man

Joint UK guideline (2006) recommends that routine testing of thyroid function (TFT) in patients admitted acutely to hospital is not warranted unless specific clinical indications exist. Despite this, TFT is frequently requested during acute medical admission. In our previous audit in 2002, during a 1 month period from 18th September, 458 subjects were admitted to medical assessment unit (MAU) and 183 (40%) were offered TFT. 39 (29%) results were beyond the laboratory reference...